BlackRock High Yield Trust 

(Public, NYSE:BHY)   Watch this stock   
Find more results for BHY

Address

100 Bellvue Parkway
Wilmington, DE 19809
United States - Map

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

BlackRock High Yield Trust discussed on blogs

Ranking U.K. Stocks by Price Momentum as of Feb 7, 2010 - NASD100 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Feb 8, 2010
BEST-Rated U.K. Stocks as of Feb 7, 2010 - NASD100.com - Daily ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Feb 7, 2010

BlackRock High Yield Trust discussions

  View all discussions »

Description

BlackRock High Yield Trust (the Trust) is a diversified, closed-end management investment company. The Trust seeks to provide high current income, and to a lesser extent, capital appreciation, by investing in a diversified portfolio of below investment-grade securities. It invests in industries, such as building products, paper and forest products, aerospace and defense, airfreight and logistics, airlines, auto components, automobiles, diversified telecommunications services, chemicals and hotels, restaurants and leisure. The Trust’s investment advisor is BlackRock Advisors, LLC.

Officers and directors

Donald C. Burke
President, Chief Executive Officer
Age: 49
Bio & Compensation - Reuters
Karen P. Robards
Vice Chairman of the Board of Trustees
Age: 59
Bio & Compensation - Reuters
Neal J. Andrews
Chief Financial Officer
Age: 43
Bio & Compensation - Reuters
Anne F. Ackerley
Vice President
Age: 47
Bio & Compensation - Reuters
Brian P. Kindelan
Chief Compliance Officer
Age: 50
Bio & Compensation - Reuters
Jay M. Fife
Treasurer
Age: 39
Bio & Compensation - Reuters
Howard B. Surloff
Secretary
Age: 44
Bio & Compensation - Reuters
Richard E. Cavanagh
Trustee
Age: 63
Bio & Compensation - Reuters
Kent Dixon
Trustee
Age: 72
Bio & Compensation - Reuters
Frank J. Fabozzi
Trustee
Age: 61
Bio & Compensation - Reuters